AstraZeneca Says Reports COVID-19 Vaccine Efficacy Is Low in Seniors Are Incorrect

Reuters says AstraZeneca has disputed claims from German media that its COVID-19 vaccine shows little effectiveness in older adults. The drugmaker earlier this week dismissed reports from German daily papers Handelsblatt and Bild as "completely incorrect." The publications alleged separately that the vaccine — which AstraZeneca co-developed with Oxford University — had an efficacy of 8 percent or less than 10 percent, respectively, in people over 65. Moreover, the papers said the German government did not expect the European regulator to clear the vaccine for that age group.